Artwork

Konten disediakan oleh Peter Attia, MD, Peter Attia, and MD. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Peter Attia, MD, Peter Attia, and MD atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !

#289 - AMA #56: Cancer screening: pros and cons, screening options, interpreting results, and more

20:44
 
Bagikan
 

Manage episode 400554412 series 2394217
Konten disediakan oleh Peter Attia, MD, Peter Attia, and MD. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Peter Attia, MD, Peter Attia, and MD atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter’s Weekly Newsletter

In this “Ask Me Anything” (AMA) episode, the conversation focuses on cancer screening, a topic often shrouded in confusion yet crucial to understand given that early identification of a cancer is an essential part of survival strategy. Peter examines the arguments both for and against cancer screening, including addressing why some trials may show no benefit to screening. He then delves into the various screening modalities available for different cancers, highlights the pros and cons associated with each, and explains how to interpret the results. Additionally, Peter provides guidance for navigating outside of the relatively narrow and confined screening guidelines for various types of screening tests.

If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #56 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

  • Why understanding cancer screening is crucial [2:45];
  • The prevalence of cancer diagnosis and mortality rates [4:30];
  • Why cancer screening and early detection is such an important part of the strategy to survive a cancer diagnosis [11:00];
  • Data on how cancer screening impacts survivability of cancer [16:30];
  • Inconsistencies between cancer screening trials regarding benefits to survival rates [25:45];
  • What are some of the reasons why clinical trials don’t always improve cancer-specific mortality? [30:15];
  • What are the arguments against population-level cancer screening? [42:00];
  • Cancer screening outside the recommended guidelines: risks and benefits, interpreting results, and other considerations [46:00];
  • Understanding sensitivity and specificity when reviewing screening results [52:30];
  • Risks and complications associated with colonoscopies [55:45];
  • Cancer screening modalities: options for cancer screening both within standard recommendations and beyond [58:30];
  • The strengths and limitations of various types of cancer screening [1:02:15];
  • Understanding positive and negative predictive value using sensitivity, specificity, and pretest probability [1:11:45];
  • Factors that influence an individual's pretest probability of cancer [1:13:45];
  • How to interpret cancer screening results [1:18:15];
  • The importance of having an advocate when considering out-of-guideline cancer screening tests [1:23:30];
  • How stacking multiple cancer screening modalities can decrease the risk of false positives [1:29:30];
  • Advice and guidance for making decisions related to cancer screening [1:31:15]; and
  • More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube

  continue reading

351 episode

Artwork
iconBagikan
 
Manage episode 400554412 series 2394217
Konten disediakan oleh Peter Attia, MD, Peter Attia, and MD. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Peter Attia, MD, Peter Attia, and MD atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter’s Weekly Newsletter

In this “Ask Me Anything” (AMA) episode, the conversation focuses on cancer screening, a topic often shrouded in confusion yet crucial to understand given that early identification of a cancer is an essential part of survival strategy. Peter examines the arguments both for and against cancer screening, including addressing why some trials may show no benefit to screening. He then delves into the various screening modalities available for different cancers, highlights the pros and cons associated with each, and explains how to interpret the results. Additionally, Peter provides guidance for navigating outside of the relatively narrow and confined screening guidelines for various types of screening tests.

If you’re not a subscriber and are listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #56 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

We discuss:

  • Why understanding cancer screening is crucial [2:45];
  • The prevalence of cancer diagnosis and mortality rates [4:30];
  • Why cancer screening and early detection is such an important part of the strategy to survive a cancer diagnosis [11:00];
  • Data on how cancer screening impacts survivability of cancer [16:30];
  • Inconsistencies between cancer screening trials regarding benefits to survival rates [25:45];
  • What are some of the reasons why clinical trials don’t always improve cancer-specific mortality? [30:15];
  • What are the arguments against population-level cancer screening? [42:00];
  • Cancer screening outside the recommended guidelines: risks and benefits, interpreting results, and other considerations [46:00];
  • Understanding sensitivity and specificity when reviewing screening results [52:30];
  • Risks and complications associated with colonoscopies [55:45];
  • Cancer screening modalities: options for cancer screening both within standard recommendations and beyond [58:30];
  • The strengths and limitations of various types of cancer screening [1:02:15];
  • Understanding positive and negative predictive value using sensitivity, specificity, and pretest probability [1:11:45];
  • Factors that influence an individual's pretest probability of cancer [1:13:45];
  • How to interpret cancer screening results [1:18:15];
  • The importance of having an advocate when considering out-of-guideline cancer screening tests [1:23:30];
  • How stacking multiple cancer screening modalities can decrease the risk of false positives [1:29:30];
  • Advice and guidance for making decisions related to cancer screening [1:31:15]; and
  • More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube

  continue reading

351 episode

Semua episode

×
 
Loading …

Selamat datang di Player FM!

Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.

 

Panduan Referensi Cepat